Turkish Version of the Headache Screening Questionnaire
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBaşakşehir Çam & Sakura City Hospital
About this trial
This multi-center, nationwide study aims to evaluate the validity and reliability of the Turkish version of the Headache Screening Questionnaire (HSQ-TR). The 10-item questionnaire is designed to screen for migraine and tension-type headache in individuals with headache complaints.
Participants presenting with headache will be enrolled. Each participant will first complete the HSQ-TR and then be examined by a neurologist who will provide a diagnosis according to the ICHD-3 beta criteria. The questionnaire results will be compared with the neurologist's diagnoses to assess criterion validity, including sensitivity, specificity, and agreement.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals aged 18 and over who present with headache complaints (migraine or tension-type) and voluntarily agree to participate
Disqualifiers
Individuals with severe psychiatric disorders, illiteracy in Turkish, or significant cognitive impairment preventing comprehension of the scale
Trial population
Adult patients (≥18 years old) presenting with headache complaints (migraine or tension-type headache) at outpatient neurology clinics in participating hospitals. Participants must be literate in Turkish and cognitively capable of completing self-report questionnaires. A total of 100 patients will be enrolled across multiple centers in Turkey.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Headache Screening Questionare
Diagnostic testThe Headache Screening Questionnaire (HSQ) is a 10-item tool developed to screen for migraine and tension-type headache (TTH), based on the ICHD-3 beta criteria. Each item reflects a diagnostic criterion for migraine or TTH. Participants complete the HSQ and are also evaluated by a neurologist for diagnosis. A score of 6 or higher suggests "probable migraine" or "probable TTH."
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: Patients with headache1 intervention
Trial outcomes
Primary outcomes
1
ICHD-3 Beta Classification
Time frame
Day 1, Two weeks later control2
Headache Screening Questionare
Time frame
Day 1,Two weeks later controlLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Başakşehir Çam & Sakura City Hospital
Lead sponsor
Umraniye Education and Research Hospital
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: